Company Profile
Bio-Techne Stock Price, News & Analysis
- Ticker:
- TECH
- Exchange:
- NASDAQ
- Sector:
- Life Science Tools
- Location:
- United States
Stock performance
71.90 USD (-0.14%)
Close
Last updated: August 6, 2026
7.79B USD
Market cap
Why the stock is moving
As of Aug 6, 2026, TECH was little changed and closed at $71.90. No new same-company headline was identified in the current news window.
Company overview
Life-Science Research Tools
Bio-Techne supplies proteins, reagents, instruments and diagnostic products used across biological research, drug development, manufacturing and clinical testing. Its catalog of more than 500,000 products serves academic laboratories, biotechnology and pharmaceutical companies, and clinical diagnostic customers worldwide.
R&D Systems
R&D Systems supports discovery, translational research and bioprocessing with proteins, antibodies, assays and related reagents. The portfolio includes GMP-grade proteins used in cell and gene therapy development and manufacturing.
Bio-Techne Spatial
The Spatial business provides technologies for analyzing the location and expression of biological targets within tissue. These tools help researchers connect molecular signals with tissue architecture in areas such as oncology and translational medicine.
Bio-Techne Diagnostics
The Diagnostics portfolio includes immunoassays, blood chemistry and blood gas quality controls, hematology controls, and bulk or custom reagents for in vitro diagnostic manufacturers and clinical laboratories.
Future catalysts
Bio-Techne’s watchlist is protein-tools demand, spatial-biology adoption, and bioprocess recovery. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
Recent news
- 01
- 02
- 03
- 04
Bio-Techne Declares Dividend
Source: Bio-Techne
- 05
Bio-Techne Releases Third Quarter Fiscal 2026 Results
Source: Bio-Techne
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Bio-Techne (TECH)?
Bio-Techne (TECH) most recently closed at 71.90 USD, a -0.14% move versus the previous session.
What is the market cap of Bio-Techne (TECH)?
Bio-Techne currently has a market capitalization of 7.79B USD on BioPharmSignal.
What does Bio-Techne do?
Life-Science Research Tools Bio-Techne supplies proteins, reagents, instruments and diagnostic products used across biological research, drug development, manufacturing and clinical testing. Its catalog of more than 500,000 products serves academic laboratories, biotechnology and pharmaceutical companies, and clinical diagnostic customers worldwide. R&D...
On which exchange is TECH stock listed?
Bio-Techne (TECH) is associated with NASDAQ, United States, Life Science Tools.
What is Life-Science?
Life-Science Research Tools Bio-Techne supplies proteins, reagents, instruments and diagnostic products used across biological research, drug development, manufacturing and clinical testing.
Which conditions is Bio-Techne targeting with Life-Science?
Bio-Techne is associated with oncology, hematology based on its company overview and current catalyst commentary.
How does Bio-Techne describe recent progress with Life-Science?
Bio-Techne’s watchlist is protein-tools demand, spatial-biology adoption, and bioprocess recovery. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
What is Research?
Life-Science Research Tools Bio-Techne supplies proteins, reagents, instruments and diagnostic products used across biological research, drug development, manufacturing and clinical testing.